Connect with us

Hi, what are you looking for?

press release

Umbilical Cord Blood (UCB) Market Set To Witness a CAGR of

#Umbilical #Cord #Blood #UCB #Market #Set #Witness #CAGR

Dallas, Texas, Oct. 14, 2022 (GLOBE NEWSWIRE) — The size of the Global Umbilical Cord Blood (UCB) market is anticipated to increase at a CAGR of 16.68% from 2022 to 2029, reaching US$ 12.16 billion.

A substantial increase in chronic diseases inclusive of most cancers, diabetes, a blood disorder, immune disease, metabolic disorder, and so forth has increased the need for a price-effective and efficient manner of treatment. But, umbilical cord blood has the capability to treat these continual illnesses effectively is an important component using the growth of the Umbilical cord Blood (UCB) market. Umbilical cord blood is extracted from the umbilical cord of newborns and also from the placenta after birth. It is rich in adult stem cells, and these stem cells play an important role in the regulation of all biological activities and the development of human tissues.

Request for a sample report here: https://www.adroitmarketresearch.com/contacts/request-sample/3551

Since umbilical cord blood contains stem cells required to treat hematopoiesis and genetic abnormalities, it is generated and kept in either liquid or vapor phase nitrogen to preserve its viability and potency. It may also bring medical benefits to sick siblings and relatives. Umbilical cord blood (UCB) is utilized to rebuild bone marrow following radiation therapy for different types of anemia and blood malignancies.

Umbilical Cord Blood (UCB) Market Scope :

Metrics Details
Base Year 2021
Historic Data 2019-2020
Forecast Period 2022-2029
Study Period 2019-2029
Forecast Unit Value (USD)
Revenue forecast in 2029 USD 12.16 billion
By Product Type Regenerative Medicine, Transplant Medicine, Allogenic Transplant, Autologous Transplant, Stem Cell Transplant
By Distribution Channel Public and Private Cord Bank, Research-Based Pharmaceutical Companies, Academic Institutes, Therapeutics Service Companies
Key Players Profiled Cytori, Mesoblast, ATCC, NeoStem, Opexa…

Read on GNW: Umbilical Cord Blood (UCB) Market Set To Witness a CAGR of

You May Also Like

Business

State would join dozens of others in enacting legislation based on federal government’s landmark whistleblower statute, the False Claims Act

press release

With a deep understanding of the latest tech, Erbo helps businesses flourish in a digital world.

press release

#Automotive #Carbon #Canister #Market #Projected #Hit #USD New York, US, Oct. 24, 2022 (GLOBE NEWSWIRE) —  According to a comprehensive research report by Market...

press release

Barrington Research Analyst James C.Goss reiterated an Outperform rating on shares of IMAX Corp IMAX with a Price target of $20. As theaters...